Everyone knows that the path of least resistance is the path that will always be taken, be it by water, electricity or the ...

What To Know: After the market close on Tuesday, S&P Dow Jones Indices announced that agentic automation company UiPath will replace Synovus Financial Corp (NYSE: SNV) in the S&P MidCap 400, effective ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. In October 2024, news broke that Facebook parent company Meta had cracked an "impossible" problem ...

In October 2024 Luke Durant, an independent researcher in San Jose, Calif., announced that he had discovered the largest known prime number—so enormous it would take years to write out in full. One ...

Kids in elementary school learn—or are supposed to learn—how to add fractions and round numbers. But many students at the University of California, San Diego—a top public university ranked sixth ...

Journal Editorial Report: The week's best and worst from Kim Strassel, Jason Riley and Dan Henninger. Remember when the University of California kicked off a trend by eliminating the SAT test as an ...

A new demo of Google’s Nano Banana Pro has set social media buzzing, thanks to a viral post showcasing just how precisely the tool can read and recreate handwritten work. The now-popular image shared ...

The Texas Longhorns have fading College Football Playoff hopes, but a win Saturday at home over the Arkansas Razorbacks will keep the dream alive in time for a Thanksgiving weekend showdown with No. 3 ...

Exact agreed to be bought out by Abbott Labs for $105 per share. The buyout is at a hefty premium to the share price at the start of the week, but still well below Exact's 2021 highs. Shareholders ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

The cancer diagnostics specialist might, just might, be on the verge of selling itself. The apparent would-be buyer is a top name in the U.S. pharmaceutical industry. A strategic investor is ...